DI COSTANZO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.022
EU - Europa 1.569
AS - Asia 748
SA - Sud America 77
AF - Africa 13
OC - Oceania 6
Totale 4.435
Nazione #
US - Stati Uniti d'America 2.000
RU - Federazione Russa 605
PL - Polonia 422
SG - Singapore 225
CN - Cina 172
IT - Italia 151
HK - Hong Kong 142
IE - Irlanda 119
SE - Svezia 104
KR - Corea 68
BR - Brasile 65
VN - Vietnam 39
DE - Germania 38
JO - Giordania 34
IN - India 31
FI - Finlandia 25
GB - Regno Unito 23
FR - Francia 20
ID - Indonesia 18
CA - Canada 12
AT - Austria 11
ES - Italia 11
UA - Ucraina 11
JP - Giappone 8
BE - Belgio 7
CH - Svizzera 7
MX - Messico 7
AU - Australia 6
NL - Olanda 5
AR - Argentina 4
IQ - Iraq 4
MA - Marocco 4
VE - Venezuela 4
ZA - Sudafrica 4
IL - Israele 3
LT - Lituania 3
CI - Costa d'Avorio 2
HR - Croazia 2
UY - Uruguay 2
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
LV - Lettonia 1
NI - Nicaragua 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.435
Città #
Santa Clara 502
Warsaw 422
Ashburn 209
Fairfield 209
Singapore 139
Hong Kong 123
Dublin 119
Chandler 116
Seattle 84
Woodbridge 77
Cambridge 68
Seoul 68
Houston 67
Wilmington 65
Beijing 53
Lawrence 43
Altamura 42
Ann Arbor 41
Buffalo 37
Moscow 31
Princeton 31
Florence 25
Boston 24
Los Angeles 23
Munich 23
Mumbai 20
New York 20
Dong Ket 18
Hefei 18
Shanghai 18
Boardman 17
Dallas 16
Jakarta 16
Pisa 14
Rome 13
Medford 12
San Diego 11
Turku 11
Clifton 10
Vienna 10
Paris 9
The Dalles 9
Redondo Beach 8
Bern 7
Brussels 7
Pune 7
Redwood City 7
Tokyo 7
Barcelona 6
Norwalk 6
São Paulo 6
Toronto 6
Helsinki 5
London 5
Melbourne 5
Bremen 4
Curitiba 4
Falls Church 4
Hillsboro 4
Ho Chi Minh City 4
Johannesburg 4
Kent 4
Milan 4
Yubileyny 4
Amman 3
Atlanta 3
Charlotte 3
Frankfurt am Main 3
Guangzhou 3
Hanoi 3
Lucca 3
Mexico City 3
Mykolayiv 3
Shenzhen 3
Abidjan 2
Amsterdam 2
Bengaluru 2
Cantu 2
Casablanca 2
Cinisello Balsamo 2
Conversano 2
Elk Grove Village 2
Hangzhou 2
Isidro Casanova 2
Jönköping 2
Laurel 2
Montevideo 2
Nanjing 2
Newark 2
Nuremberg 2
Orem 2
Ottawa 2
Owings Mills 2
Padova 2
Perugia 2
Phoenix 2
Pietrasanta 2
Prato 2
Redmond 2
Rio Grande 2
Totale 3.083
Nome #
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 310
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 243
Adjuvant chemotherapy in completely resected gastric cancer: A randomized phase III trial conducted by GOIRC 231
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 218
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 200
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 198
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 196
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation 177
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 175
Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report 175
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 164
Circulating tumour cells in colorectal cancer 163
Physical exercise and eating habits in cancer survivors 163
Effects of a home based exercise rehabilitation program for cancer survivors 155
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 151
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 151
Temperament and character traits associated with health-related quality of life in cancer patients 136
A transcriptomic approach reveals selective ribosomal remodelling in the tumour versus the stromal compartment of metastatic colorectal cancer 130
Regorafenib also can cause osteonecrosis of the jaw 129
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status 127
Bevacizumab in non-small cell lung cancer 124
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas 118
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. 118
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 117
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer 117
A multi-center study on the surgical management of metastatic disease to adrenal glands 116
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study 115
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 85
Totale 4.502
Categoria #
all - tutte 13.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021327 0 0 0 0 0 53 39 40 53 83 32 27
2021/2022224 8 17 21 8 5 15 5 15 19 13 31 67
2022/2023608 57 131 33 27 38 110 76 36 68 5 15 12
2023/2024225 3 19 28 12 10 50 15 47 2 16 12 11
2024/20251.542 45 151 79 285 437 206 22 66 75 46 64 66
2025/2026739 175 197 88 87 181 11 0 0 0 0 0 0
Totale 4.502